Fresenius Kabi seeks FDA approval for innovative plasmapheresis software

Fresenius Kabi, a global healthcare company, has filed a 510(k) notification with the U.S. Food and Drug Administration (FDA) for its Aurora Xi Plasmapheresis System ... Read More